Fundraising FoxK2
11 known investors
Find your way into K2
Sign up to see every warm intro you have to K2
- Paths you didn't know you had: your email and LinkedIn already hold routes to the K2 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
K2 Therapeutics is a biotech company that identifies innovative drug assets and develops them into medicines using a hub-and-spoke model with cross-regional clinical trials. Its pipeline focuses on first- and best-in-class cell therapies for solid tumors, including a PRAME-targeting therapy for cutaneous melanoma and synovial sarcoma.
Investors · 11
How we know: funding news · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does K2 do?
- K2 Therapeutics is a biotech company that identifies innovative drug assets and develops them into medicines using a hub-and-spoke model with cross-regional clinical trials. Its pipeline focuses on first- and best-in-class cell therapies for solid tumors, including a PRAME-targeting therapy for cutaneous melanoma and synovial sarcoma.
- Who are K2's investors?
- K2's investors include MPM BioImpact, Alpine Space Ventures, Altimeter Capital, CapitalG, ICONIQ, Kleiner Perkins, Lightspeed Venture Partners, Redpoint Ventures and 3 more.